Theron Taber Returns to assisTek to Support Continued Growth in Innovative ePRO Solutions in Clinical Trials

Share Article

assisTek, Leader in Innovative Electronic Patient Reported Outcomes (ePRO) Solutions and Patient Questionnaires for Clinical Trials announces the return of Theron Taber

assisTek today is pleased to announce the return of Theron Taber from medical leave. Theron was a founder of assisTek in 1994 and had been instrumental in building relationships and securing clinical trials with the industry's top pharmaceutical companies.    “I am happy to be back at assisTek and am pleased to support assisTek’s leadership position in the ePRO market with their exciting new smart phone and netbook products," says Theron.    “Theron’s industry knowledge is vast, and I look forward to working with him again. The assisTek team has always benefited from Theron’s perspective and his many years experience,” says Joy Hebert, his co-founder.

Theron’s role at assisTek will be to continue to build and develop new relationships within industry and to work with the assisTek team to continue to provide innovative ePRO solutions to pharmaceutical and biotechnology clinical trial clients. Theron will also be a member of senior management teams that lead and set direction for assisTek. Theron encourages old friends and colleagues to say hello and get in touch with him using the contact information on this news release.

About assisTek
assisTek is the global leader in ePRO systems and has revolutionized the process of collecting patient-reported outcomes in clinical trials by helping sites collect the data electronically through innovation, using touch-screens tablets, internet, Apple iPhones/smart phones, and netbooks. For more information about assisTek's ePRO systems or to schedule a free no-obligation demonstration, contact assisTek. The assisTek team has more than 45,000 patients in more than 35 therapeutic areas at more than 4,500 sites across 5 continents. Visit assisTek online at


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Theron Taber
480-874-9400 ext. 333
Email >
Visit website